Literature DB >> 14354564

Latent carcinoma of the prostate.

L M FRANKS.   

Abstract

Entities:  

Keywords:  PROSTATE/neoplasms

Mesh：

Year:  1954        PMID： 14354564     DOI： 10.1002/path.1700680233

Source DB:  PubMed          Journal:  J Pathol Bacteriol        ISSN： 0368-3494


× No keyword cloud information.
  56 in total

1.  System for MR image-guided prostate interventions: canine study.

Authors:  Robert C Susil; Axel Krieger; J Andrew Derbyshire; Attila Tanacs; Louis L Whitcomb; Gabor Fichtinger; Ergin Atalar
Journal:  Radiology       Date:  2003-09       Impact factor: 11.105

2.  Management of early prostatic carcinoma.

Authors:  R W BARNES; D S EMERY
Journal:  Calif Med       Date:  1959-08

3.  Some aspects of the conservative management of prostatic cancer.

Authors:  J D FERGUSSON
Journal:  Proc R Soc Med       Date:  1963-02

4.  Cytological diagnosis of prostatic carcinoma.

Authors:  J BAMFORTH
Journal:  Ann R Coll Surg Engl       Date:  1958-10       Impact factor: 1.891

5.  [Development of microcarcinomas in cirrhotic livers].

Authors:  K KOHN
Journal:  Z Krebsforsch       Date:  1956

6.  [Research on the fate of patients with histologically diagnosed prostate carcinoma].

Authors:  C FABRY
Journal:  Z Krebsforsch       Date:  1955

7.  Early (stage A) prostatic cancer. IV. Methodological criteria for histopathological diagnosis.

Authors:  S Battaglia; G Barbolini; A R Botticelli
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979-06-29

8.  Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

Authors:  N Weidner; P R Carroll; J Flax; W Blumenfeld; J Folkman
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

9.  Prostate cancer screening (United States).

Authors:  J W Waterbor; A J Bueschen
Journal:  Cancer Causes Control       Date:  1995-05       Impact factor: 2.506

10.  Expression of metalloproteinase genes in human prostate cancer.

Authors:  M S Pajouh; R B Nagle; R Breathnach; J S Finch; M K Brawer; G T Bowden
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.